Eden Prairie-based Celleration has raised $8 million in Series E stock toward more sales and marketing resources for its mist therapy wound healing product. Celleration’s product, Mist Therapy System, ...
The economic evidence for the MIST Therapy system comprised an unpublished cost-effectiveness study, a conference poster and a new cost analysis. An unpublished study from the USA considered the ...
EDEN PRAIRIE, Minn., March 26, 2015 /PRNewswire/ -- Celleration, Inc., a privately-held medical device company focused on developing and commercializing therapeutic ultrasound healing technologies, ...
EDEN PRAIRIE, Minn., Jan. 27, 2015 /PRNewswire/ -- Celleration, Inc., a privately-held medical device company focused on developing and commercializing therapeutic ultrasound healing technologies, ...
Wound-care outfit Alliqua BioMedical ($ALQA) shelled out $30.4 million for ultrasound therapy company Celleration, broadening its portfolio and gaining ground in ...
A wound care company enlisted the help of Logic PD design and manufacture their next generation ultrasound treatment device. The two companies worked together to create the UltraMIST therapy platform, ...
India's equity benchmarks are likely to open little changed on Monday as sentiment remained gloomy after the previous week's sell-off in IT stocks, with foreign investors going back to being net ...
The first clinical trial resulting from NICE medical technology guidance recommendations is due to start soon on a device to promote wound healing. NICE issued guidance in 2011 strongly encouraging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results